A major development has taken place with the launch of new investment in the health sector a $10 million project has been initiated for the production of advanced medicines.
Heads of Chinese and German pharmaceutical companies met with the Federal Minister for Health, where discussions were held on promoting local drug manufacturing, technology transfer, and export enhancement in Pakistan.
The German pharmaceutical company briefed the Minister of Health on ongoing projects related to diabetes treatment and reaffirmed its long-term commitment to Pakistan’s health sector.
The Chinese pharmaceutical company will enhance research collaboration with Pakistan and informed the minister about its plans to establish a modern production facility in the country.
Representatives of Chinese pharmaceutical companies agreed to expand research cooperation with Pakistan. According to the plan, pre-filled syringes, semaglutide tablets, and GLP-1 injections will be locally manufactured.
With an initial investment of 10 million US dollars, a state of the art pharmaceutical manufacturing facility will be established.
Mustafa Kamal said that the government welcomes foreign investment to achieve this goal. He invited both companies to present a detailed roadmap for phased investment and project implementation.
The Health Minister stated that the Government of Pakistan is committed to providing all possible facilities to foreign investors. This collaboration will not only be limited to investment but will also create employment opportunities and enhance export potential.
Mustafa Kamal added that the Government of Pakistan will ensure timely compliance with all relevant regulatory requirements, aiming to transform Pakistan from an import-dependent pharmaceutical economy into a self sufficient and export oriented one.
The Health Minister further stated that, in line with the Prime Minister’s vision, effective measures are being ensured to increase exports from Pakistan.
